A Proof of Concept Study of the Efficacy and Safety of Oral LAT8881 in Acute Migraine
Clinical trial NCT04153409 · COMPLETED
Trial details
- NCT number
- NCT04153409
- Sponsor
- Lateral Pharma Pty Ltd
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-24
- Primary completion
- 2020-02-15
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.